Answers are grounded in this paper and cite their sources.
Demonstrates enhanced detection sensitivity for NSCLC-related microRNA in bioanalysis, suggesting potential for lung cancer diagnosis.
High Resolution Image Download MS PowerPoint Slide Lung cancer remains a leading cause of cancer-related mortality worldwide, with nonsmall cell lung cancer (NSCLC) accounting for approximately 85% of cases. Herein, we develop a split G-quadruplex-programmed fluorescent platform integrating exonuclease III (Exo-III)-assisted dual signal amplification for ultrasensitive detection of the NSCLC-related miRNA let-7a. This platform incorporates two synergistic background-suppression strategies: immobilization of sensing components on a microplate to remove interfering substances and enzymatic cleavage byproducts, and the employment of malachite green as an aggregation-induced emission fluorophore that activates only upon specific G-quadruplex binding. The Exo-III-mediated dual recycling mechanism substantially enhances detection sensitivity. Under optimized conditions, the platform achieves an exceptionally low detection limit of 0.76 fM with a wide linear range from 1 fM to 50 nM. The method exhibits excellent specificity for discriminating let-7a from homologous miRNAs, high recovery rates (97.6–104.3%) in serum samples, and strong correlation with qRT-PCR. This simple, robust platform holds great promise for early NSCLC diagnosis and clinical monitoring.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: